US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Agenus

3.06

-0.1500-4.67%

Post-market: 3.070.0083+0.27%18:46 EST

Volume:400.42K

Turnover:1.24M

Market Cap:110.59M

PE:-1.46

High:3.25

Open:3.19

Low:3.03

Close:3.21

52wk High:7.34

52wk Low:1.38

Shares:36.14M

Float Shares:33.40M

Volume Ratio:1.11

T/O Rate:1.20%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.0918

EPS(LYR):-10.5913

ROE:-1278.83%

ROA:-16.66%

PB:-0.40

PE(LYR):-0.29

Loading ...

Overview Company News Filings

Agenus Inc. Publishes Findings on Systemic and Tumor-Microenvironment Inflammation in Botensilimab-Treated Cold, Refractory Tumors

Agenus reports biomarker data showing survival stratification in MSS mCRC patients treated with botensilimab plus balstilimab

Agenus stellt neue klinische Daten zu Botensilimab bei therapieresistenten Tumoren vor

Analysts Offer Insights on Healthcare Companies: Argenx Se (ARGX), Agenus (AGEN) and Assertio Therapeutics (ASRT)

Agenus Expands Medical Affairs Infrastructure Amid Rising Demand for Botensilimab Access

Agenus Launches Stakeholder Webcast Showcasing Global Momentum for BOT+BAL Program

Agenus Inc. Files Initial Beneficial Ownership Statement for Principal Accounting Officer Austin Charette

Agenus Forms Major Strategic Collaboration with Zydus Lifesciences

Agenus Falls After $141M Zydus Deal Closes

Zydus Lifesciences Closes Acquisition of Agenus Biologics Facilities and Launches Zylidac Bio in US

Agenus Closes $141M Strategic Collaboration with Zydus Lifesciences

Agenus Consolidates Financial Leadership With Interim CFO Appointment

Agenus Inc - Effective Jan 8, Appointed CEO Garo Armen as Interim CFO - SEC Filing

THOMSON REUTERS

Agenus Names CEO Garo Armen as Interim CFO, Appoints Austin Charette as Principal Accounting Officer

Agenus Inc - France's Ansm Approves Updated Protocol for Botensilimab + Balstilimab

THOMSON REUTERS

Agenus Inc - BOT+Bal Remains Investigational, Not Approved for Marketing in France or Elsewhere

THOMSON REUTERS

France Expands Compassionate Access for Agenus Botensilimab and Balstilimab Combination

Agenus amends Ligand agreement, modifies warrant holder rights

Agenus Reports Promising Results for Botensilimab and Balstilimab in Refractory Ovarian Cancer Trial

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:33 AM

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/AGEN/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AGEN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AGEN\",,,,,undefined,":{"symbol":"AGEN","market":"US","secType":"STK","nameCN":"Agenus","latestPrice":3.06,"timestamp":1771621200000,"preClose":3.21,"halted":0,"volume":400415,"hourTrading":{"tag":"盘后","latestPrice":3.0683,"preClose":3.06,"latestTime":"18:46 EST","volume":353,"amount":1083.26,"timestamp":1771631162999,"change":0.0083,"changeRate":0.002712,"amplitude":0.003268},"delay":0,"changeRate":-0.04672897196261679,"floatShares":33404954,"shares":36141700,"eps":-2.0918,"marketStatus":"Market Closed","change":-0.15,"latestTime":"02-20 16:00:00 EST","open":3.19,"high":3.245,"low":3.03,"amount":1241050.8557725,"amplitude":0.066978,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.0918,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771837200000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":949640400000,"exchange":"NASDAQ","adjPreClose":3.21,"postHourTrading":{"tag":"盘后","latestPrice":3.0683,"preClose":3.06,"latestTime":"18:46 EST","volume":353,"amount":1083.26,"timestamp":1771631162999,"change":0.0083,"changeRate":0.002712,"amplitude":0.003268},"volumeRatio":1.1076146851735402,"impliedVol":1.0378,"impliedVolPercentile":0.5498},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AGEN\",,,,,undefined,":{"symbol":"AGEN","floatShares":33404954,"roa":"-16.66%","roe":"-1278.83%","lyrEps":-10.5913,"volumeRatio":1.1076146851735402,"shares":36141700,"dividePrice":0,"high":3.245,"amplitude":0.066978,"preClose":3.21,"low":3.03,"week52Low":1.38,"pbRate":"-0.40","psRate":"1.04","week52High":7.34,"institutionHeld":0.0231,"latestPrice":3.06,"eps":-2.0918,"divideRate":0,"volume":400415,"delay":0,"ttmEps":-2.0918,"open":3.19,"prevYearClose":3.14,"prevWeekClose":2.92,"prevMonthClose":2.84,"prevQuarterClose":3.14,"fiveDayClose":2.85,"twentyDayClose":3.38,"sixtyDayClose":4.22,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AGEN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-10","symbol":"AGEN","fiscalQuarterEnding":"2025/09","expectedEps":2.31,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762750800000,"reportTimeType":"pre","actualEps":1.94},{"market":"US","date":"2025-08-11","symbol":"AGEN","fiscalQuarterEnding":"2025/06","expectedEps":-0.78,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754884800000,"reportTimeType":"pre","actualEps":1},{"market":"US","date":"2025-05-12","symbol":"AGEN","fiscalQuarterEnding":"2025/03","expectedEps":-1.61,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"pre","actualEps":-1.03},{"market":"US","date":"2025-03-11","symbol":"AGEN","fiscalQuarterEnding":"2024/12","expectedEps":-2.36,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1741665600000,"reportTimeType":"pre","actualEps":-2.04},{"market":"US","date":"2024-11-12","symbol":"AGEN","fiscalQuarterEnding":"2024/09","expectedEps":-2.1,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-3.17}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AGEN\",market:\"US\",,,undefined,":[{"executeDate":"2023-04-26","recordDate":"2023-04-17","paymentDate":"2023-05-01","value":0.0146,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AGEN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.6667,"hold":0.3333,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1749013200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AGEN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AGEN","date":"2026-02-19","current":-1.462855,"percent":0.342149,"low":-44.01113,"twenty":-4.296149,"median":-1.274554,"eighty":-0.36068,"high":287.304865,"avg":10.129693,"sd":50.855728,"marketCap":104745714},"quantilePoints":[{"date":"2021-02-26","current":-4.387335,"twenty":-4.697581,"median":-3.826602,"eighty":-2.836115,"marketCap":760597204},{"date":"2021-03-05","current":-3.509868,"twenty":-4.671003,"median":-3.822098,"eighty":-2.831819,"marketCap":608477763},{"date":"2021-03-12","current":-3.63052,"twenty":-4.639385,"median":-3.81323,"eighty":-2.831819,"marketCap":629394186},{"date":"2021-03-19","current":-3.507328,"twenty":-4.627212,"median":-3.795494,"eighty":-2.831819,"marketCap":634524808},{"date":"2021-03-26","current":-3.224479,"twenty":-4.614849,"median":-3.790531,"eighty":-2.836115,"marketCap":583353452},{"date":"2021-04-01","current":-3.247107,"twenty":-4.602401,"median":-3.773042,"eighty":-2.836115,"marketCap":587447161},{"date":"2021-04-09","current":-3.150939,"twenty":-4.594045,"median":-3.76214,"eighty":-2.831819,"marketCap":570048900},{"date":"2021-04-16","current":-2.964258,"twenty":-4.583225,"median":-3.751172,"eighty":-2.831819,"marketCap":536275805},{"date":"2021-04-23","current":-3.450759,"twenty":-4.561481,"median":-3.742286,"eighty":-2.831819,"marketCap":624290537},{"date":"2021-04-30","current":-3.799279,"twenty":-4.547596,"median":-3.732192,"eighty":-2.831819,"marketCap":687342717},{"date":"2021-05-07","current":-3.595749,"twenty":-4.534042,"median":-3.718267,"eighty":-2.831819,"marketCap":682893897},{"date":"2021-05-14","current":-3.78315,"twenty":-4.517345,"median":-3.712607,"eighty":-2.831819,"marketCap":718484459},{"date":"2021-05-21","current":-4.907553,"twenty":-4.512426,"median":-3.712607,"eighty":-2.831819,"marketCap":932027827},{"date":"2021-05-28","current":-4.989541,"twenty":-4.512426,"median":-3.712607,"eighty":-2.831819,"marketCap":947598698},{"date":"2021-06-04","current":-4.720153,"twenty":-4.512426,"median":-3.712607,"eighty":-2.831819,"marketCap":896437266},{"date":"2021-06-11","current":-6.067095,"twenty":-4.512426,"median":-3.712607,"eighty":-2.831819,"marketCap":1152244426},{"date":"2021-06-18","current":-6.160795,"twenty":-4.512426,"median":-3.712607,"eighty":-2.831819,"marketCap":1170039707},{"date":"2021-06-25","current":-6.289633,"twenty":-4.512426,"median":-3.712607,"eighty":-2.831819,"marketCap":1194508218},{"date":"2021-07-02","current":-6.465321,"twenty":-4.512426,"median":-3.712607,"eighty":-2.831819,"marketCap":1227874369},{"date":"2021-07-09","current":-6.605871,"twenty":-4.512426,"median":-3.712607,"eighty":-2.831819,"marketCap":1254567290},{"date":"2021-07-16","current":-6.313058,"twenty":-4.512426,"median":-3.712607,"eighty":-2.831819,"marketCap":1198957038},{"date":"2021-07-23","current":-6.582446,"twenty":-4.512426,"median":-3.712607,"eighty":-2.831819,"marketCap":1250118470},{"date":"2021-07-30","current":-6.067095,"twenty":-4.512426,"median":-3.712607,"eighty":-2.831819,"marketCap":1152244426},{"date":"2021-08-06","current":-6.594159,"twenty":-4.512426,"median":-3.712607,"eighty":-2.831819,"marketCap":1252342880},{"date":"2021-08-13","current":-6.351279,"twenty":-4.512426,"median":-3.712607,"eighty":-2.831819,"marketCap":1433655066},{"date":"2021-08-20","current":-6.248006,"twenty":-4.512426,"median":-3.712607,"eighty":-2.831819,"marketCap":1410343602},{"date":"2021-08-27","current":-6.464879,"twenty":-4.512426,"median":-3.712607,"eighty":-2.831819,"marketCap":1459297677},{"date":"2021-09-03","current":-6.289315,"twenty":-4.516653,"median":-3.714145,"eighty":-2.836115,"marketCap":1419668188},{"date":"2021-09-10","current":-6.712733,"twenty":-4.516653,"median":-3.714145,"eighty":-2.836115,"marketCap":1515245192},{"date":"2021-09-17","current":-6.020806,"twenty":-4.516653,"median":-3.714145,"eighty":-2.836115,"marketCap":1359058380},{"date":"2021-09-24","current":-6.093097,"twenty":-4.516653,"median":-3.714145,"eighty":-2.836115,"marketCap":1375376405},{"date":"2021-10-01","current":-5.494114,"twenty":-4.516653,"median":-3.714145,"eighty":-2.836115,"marketCap":1240169911},{"date":"2021-10-08","current":-5.907205,"twenty":-4.516653,"median":-3.714145,"eighty":-2.836115,"marketCap":1333415769},{"date":"2021-10-15","current":-5.483787,"twenty":-4.516653,"median":-3.714145,"eighty":-2.836115,"marketCap":1237838764},{"date":"2021-10-22","current":-4.14124,"twenty":-4.510274,"median":-3.714145,"eighty":-2.836115,"marketCap":934789726},{"date":"2021-10-29","current":-3.965676,"twenty":-4.491197,"median":-3.714145,"eighty":-2.836115,"marketCap":895160236},{"date":"2021-11-05","current":-4.296149,"twenty":-4.50337,"median":-3.720603,"eighty":-2.836115,"marketCap":969756923},{"date":"2021-11-12","current":250.504017,"twenty":-4.492661,"median":-3.714145,"eighty":-2.767971,"marketCap":996504978},{"date":"2021-11-19","current":225.324489,"twenty":-4.480962,"median":-3.706852,"eighty":-2.716856,"marketCap":896340818},{"date":"2021-11-26","current":208.538138,"twenty":-4.480962,"median":-3.702346,"eighty":-2.673681,"marketCap":829564711},{"date":"2021-12-03","current":188.523641,"twenty":-4.480962,"median":-3.699858,"eighty":-2.645398,"marketCap":749947045},{"date":"2021-12-10","current":207.892509,"twenty":-4.480962,"median":-3.687712,"eighty":-2.594402,"marketCap":826996399},{"date":"2021-12-17","current":229.843891,"twenty":-4.480962,"median":-3.681489,"eighty":-2.55596,"marketCap":914319000},{"date":"2021-12-23","current":231.135149,"twenty":-4.480962,"median":-3.675884,"eighty":-2.518274,"marketCap":919455624},{"date":"2021-12-31","current":207.892509,"twenty":-4.480962,"median":-3.670231,"eighty":-2.488017,"marketCap":826996399},{"date":"2022-01-07","current":193.043044,"twenty":-4.478774,"median":-3.656664,"eighty":-2.484485,"marketCap":767925228},{"date":"2022-01-14","current":196.916817,"twenty":-4.478774,"median":-3.656664,"eighty":-2.460584,"marketCap":783335099},{"date":"2022-01-21","current":173.028548,"twenty":-4.478774,"median":-3.656664,"eighty":-2.442206,"marketCap":688307562},{"date":"2022-01-28","current":169.800403,"twenty":-4.476586,"median":-3.655673,"eighty":-2.416994,"marketCap":675466003},{"date":"2022-02-04","current":154.305309,"twenty":-4.476586,"median":-3.654546,"eighty":-2.368992,"marketCap":613826520},{"date":"2022-02-11","current":157.533454,"twenty":-4.476586,"median":-3.646266,"eighty":-2.309108,"marketCap":626668079},{"date":"2022-02-18","current":164.635372,"twenty":-4.473257,"median":-3.633585,"eighty":-2.287512,"marketCap":654919509},{"date":"2022-02-25","current":172.382919,"twenty":-4.472972,"median":-3.627385,"eighty":-2.273796,"marketCap":685739250},{"date":"2022-03-04","current":-31.276341,"twenty":-4.487372,"median":-3.624232,"eighty":-2.265661,"marketCap":748317732},{"date":"2022-03-11","current":-30.201553,"twenty":-4.515269,"median":-3.624232,"eighty":-2.265661,"marketCap":722602346},{"date":"2022-03-18","current":-31.813735,"twenty":-4.534668,"median":-3.624232,"eighty":-2.265661,"marketCap":761175425},{"date":"2022-03-25","current":-29.019285,"twenty":-4.545222,"median":-3.624232,"eighty":-2.265661,"marketCap":694315422},{"date":"2022-04-01","current":-27.622061,"twenty":-4.554265,"median":-3.624232,"eighty":-2.265661,"marketCap":660885420},{"date":"2022-04-08","current":-25.687441,"twenty":-4.583796,"median":-3.632439,"eighty":-2.265661,"marketCap":614597725},{"date":"2022-04-14","current":-25.150047,"twenty":-4.591972,"median":-3.639532,"eighty":-2.265661,"marketCap":601740032},{"date":"2022-04-22","current":-22.355598,"twenty":-4.602401,"median":-3.656664,"eighty":-2.265661,"marketCap":534880028},{"date":"2022-04-29","current":-20.898026,"twenty":-4.613626,"median":-3.662921,"eighty":-2.265661,"marketCap":500006178},{"date":"2022-05-06","current":-18.864705,"twenty":-4.627212,"median":-3.670231,"eighty":-2.265661,"marketCap":451356928},{"date":"2022-05-13","current":-23.781378,"twenty":-4.638718,"median":-3.674393,"eighty":-2.265661,"marketCap":441715308},{"date":"2022-05-20","current":-22.90599,"twenty":-4.670065,"median":-3.690098,"eighty":-2.265661,"marketCap":425455849},{"date":"2022-05-27","current":-23.489582,"twenty":-4.693902,"median":-3.704311,"eighty":-2.265661,"marketCap":436295489},{"date":"2022-06-03","current":-24.510868,"twenty":-4.720153,"median":-3.714507,"eighty":-2.265661,"marketCap":455264858},{"date":"2022-06-10","current":-21.301111,"twenty":-4.748522,"median":-3.733485,"eighty":-2.265661,"marketCap":395646841},{"date":"2022-06-17","current":-22.90599,"twenty":-4.769115,"median":-3.74907,"eighty":-2.265661,"marketCap":425455849},{"date":"2022-06-24","current":-28.934653,"twenty":-4.783709,"median":-3.750097,"eighty":-2.26134,"marketCap":537432248},{"date":"2022-07-01","current":-29.848379,"twenty":-4.814658,"median":-3.750097,"eighty":-2.26134,"marketCap":554403792},{"date":"2022-07-08","current":-41.269953,"twenty":-4.847014,"median":-3.750097,"eighty":-2.26134,"marketCap":766548101},{"date":"2022-07-15","current":-43.858843,"twenty":-4.889306,"median":-3.750097,"eighty":-2.26134,"marketCap":814634144},{"date":"2022-07-22","current":-40.508514,"twenty":-4.895841,"median":-3.750097,"eighty":-2.26134,"marketCap":752405147},{"date":"2022-07-29","current":-39.290213,"twenty":-4.909329,"median":-3.750097,"eighty":-2.26134,"marketCap":729776421},{"date":"2022-08-05","current":-40.356227,"twenty":-4.945769,"median":-3.750097,"eighty":-2.26134,"marketCap":749576556},{"date":"2022-08-12","current":45.998677,"twenty":-4.954877,"median":-3.740203,"eighty":-2.241781,"marketCap":840993818},{"date":"2022-08-19","current":43.210879,"twenty":-4.954877,"median":-3.718267,"eighty":-2.228928,"marketCap":790024496},{"date":"2022-08-26","current":41.352346,"twenty":-4.954877,"median":-3.706852,"eighty":-2.208814,"marketCap":756044948},{"date":"2022-09-02","current":39.803569,"twenty":-4.954877,"median":-3.693851,"eighty":-2.187438,"marketCap":727728658},{"date":"2022-09-09","current":41.662102,"twenty":-4.954877,"median":-3.677376,"eighty":-2.178074,"marketCap":761708206},{"date":"2022-09-16","current":36.241382,"twenty":-4.954877,"median":-3.663474,"eighty":-2.143769,"marketCap":662601190},{"date":"2022-09-23","current":32.98895,"twenty":-4.954877,"median":-3.652457,"eighty":-2.114419,"marketCap":603136981},{"date":"2022-09-30","current":31.749929,"twenty":-4.935664,"median":-3.633097,"eighty":-2.043977,"marketCap":580483949},{"date":"2022-10-07","current":41.507224,"twenty":-4.900526,"median":-3.619552,"eighty":-2.004987,"marketCap":758876577},{"date":"2022-10-14","current":37.790159,"twenty":-4.854232,"median":-3.602328,"eighty":-1.947842,"marketCap":690917480},{"date":"2022-10-21","current":40.887713,"twenty":-4.818365,"median":-3.587597,"eighty":-1.883135,"marketCap":747550061},{"date":"2022-10-28","current":39.493814,"twenty":-4.818365,"median":-3.577659,"eighty":-1.827749,"marketCap":722065400},{"date":"2022-11-04","current":37.790159,"twenty":-4.818365,"median":-3.57269,"eighty":-1.797631,"marketCap":690917480},{"date":"2022-11-11","current":-3.566927,"twenty":-4.818365,"median":-3.572342,"eighty":-1.787835,"marketCap":765077329},{"date":"2022-11-18","current":-4.348525,"twenty":-4.818365,"median":-3.575678,"eighty":-1.787835,"marketCap":932723756},{"date":"2022-11-25","current":-3.993253,"twenty":-4.818365,"median":-3.586647,"eighty":-1.787835,"marketCap":856520834},{"date":"2022-12-02","current":-4.220627,"twenty":-4.818365,"median":-3.595749,"eighty":-1.787835,"marketCap":905290704},{"date":"2022-12-09","current":-3.439029,"twenty":-4.818365,"median":-3.602328,"eighty":-1.787835,"marketCap":737644277},{"date":"2022-12-16","current":-3.396397,"twenty":-4.818365,"median":-3.609154,"eighty":-1.787835,"marketCap":728499927},{"date":"2022-12-23","current":-3.481662,"twenty":-4.818365,"median":-3.609226,"eighty":-1.787835,"marketCap":746788628},{"date":"2022-12-30","current":-3.410608,"twenty":-4.818365,"median":-3.609226,"eighty":-1.787835,"marketCap":731548044},{"date":"2023-01-06","current":-3.410608,"twenty":-4.818365,"median":-3.609226,"eighty":-1.787835,"marketCap":731548044},{"date":"2023-01-13","current":-4.192205,"twenty":-4.818365,"median":-3.630887,"eighty":-1.787835,"marketCap":899194470},{"date":"2023-01-20","current":-3.836934,"twenty":-4.818365,"median":-3.637981,"eighty":-1.787835,"marketCap":822991549},{"date":"2023-01-27","current":-3.737457,"twenty":-4.818365,"median":-3.636886,"eighty":-1.787835,"marketCap":801654731},{"date":"2023-02-03","current":-3.652192,"twenty":-4.818365,"median":-3.640074,"eighty":-1.787835,"marketCap":783366030},{"date":"2023-02-10","current":-3.154812,"twenty":-4.818365,"median":-3.640074,"eighty":-1.787835,"marketCap":676681940},{"date":"2023-02-17","current":-3.112179,"twenty":-4.818365,"median":-3.637981,"eighty":-1.787835,"marketCap":667537590},{"date":"2023-02-24","current":-2.813751,"twenty":-4.818365,"median":-3.636886,"eighty":-1.787835,"marketCap":603527136},{"date":"2023-03-03","current":-2.78533,"twenty":-4.787082,"median":-3.623771,"eighty":-1.787835,"marketCap":597430902},{"date":"2023-03-10","current":-2.13163,"twenty":-4.761022,"median":-3.609154,"eighty":-1.787835,"marketCap":457217527},{"date":"2023-03-17","current":-2.568557,"twenty":-4.722497,"median":-3.595749,"eighty":-1.787835,"marketCap":565272567},{"date":"2023-03-24","current":-2.251264,"twenty":-4.720153,"median":-3.586647,"eighty":-1.787835,"marketCap":495444779},{"date":"2023-03-31","current":-2.296592,"twenty":-4.720153,"median":-3.576669,"eighty":-1.787835,"marketCap":505420178},{"date":"2023-04-06","current":-2.190828,"twenty":-4.720153,"median":-3.573126,"eighty":-1.787835,"marketCap":482144248},{"date":"2023-04-14","current":-2.266374,"twenty":-4.720153,"median":-3.566927,"eighty":-1.787835,"marketCap":498769912},{"date":"2023-04-21","current":-2.538338,"twenty":-4.720153,"median":-3.566927,"eighty":-1.787835,"marketCap":558622302},{"date":"2023-04-28","current":-2.266374,"twenty":-4.720153,"median":-3.566927,"eighty":-1.787835,"marketCap":498769912},{"date":"2023-05-05","current":-2.375309,"twenty":-4.720153,"median":-3.566927,"eighty":-1.787835,"marketCap":522743683},{"date":"2023-05-12","current":-1.990022,"twenty":-4.720153,"median":-3.566927,"eighty":-1.787835,"marketCap":478327553},{"date":"2023-05-18","current":-2.136839,"twenty":-4.720153,"median":-3.566927,"eighty":-1.787835,"marketCap":512847659},{"date":"2023-05-26","current":-2.049621,"twenty":-4.720153,"median":-3.567324,"eighty":-1.787835,"marketCap":491915102},{"date":"2023-06-02","current":-2.311274,"twenty":-4.720153,"median":-3.567324,"eighty":-1.787835,"marketCap":554712774},{"date":"2023-06-08","current":-2.732828,"twenty":-4.720153,"median":-3.567324,"eighty":-1.787835,"marketCap":655886802},{"date":"2023-06-16","current":-2.631073,"twenty":-4.720153,"median":-3.570015,"eighty":-1.787835,"marketCap":631465485},{"date":"2023-06-23","current":-2.587464,"twenty":-4.720153,"median":-3.572309,"eighty":-1.812326,"marketCap":620999207},{"date":"2023-06-30","current":-2.427565,"twenty":-4.720153,"median":-3.572309,"eighty":-1.898861,"marketCap":582622851},{"date":"2023-07-07","current":-2.282202,"twenty":-4.720153,"median":-3.572325,"eighty":-1.952741,"marketCap":547735255},{"date":"2023-07-14","current":-2.689219,"twenty":-4.720153,"median":-3.572342,"eighty":-1.990022,"marketCap":645420524},{"date":"2023-07-21","current":-2.383956,"twenty":-4.721325,"median":-3.572516,"eighty":-2.032983,"marketCap":572156572},{"date":"2023-07-28","current":-2.107766,"twenty":-4.722497,"median":-3.57269,"eighty":-2.049401,"marketCap":505870140},{"date":"2023-08-04","current":-2.107766,"twenty":-4.722497,"median":-3.57269,"eighty":-2.107766,"marketCap":505870140},{"date":"2023-08-11","current":-1.908081,"twenty":-4.722497,"median":-3.57269,"eighty":-2.107766,"marketCap":501035286},{"date":"2023-08-18","current":-1.908081,"twenty":-4.722497,"median":-3.57269,"eighty":-2.107766,"marketCap":501035286},{"date":"2023-08-25","current":-1.922536,"twenty":-4.722497,"median":-3.57269,"eighty":-2.122302,"marketCap":504831008},{"date":"2023-09-01","current":-1.994812,"twenty":-4.72367,"median":-3.573126,"eighty":-2.122302,"marketCap":523809618},{"date":"2023-09-06","current":-1.85026,"twenty":-4.724842,"median":-3.573563,"eighty":-2.122823,"marketCap":485852399},{"date":"2023-09-15","current":-1.87917,"twenty":-4.730669,"median":-3.575678,"eighty":-2.125954,"marketCap":493443843},{"date":"2023-09-21","current":-1.734619,"twenty":-4.735324,"median":-3.575678,"eighty":-2.126721,"marketCap":455486624},{"date":"2023-09-27","current":-1.662343,"twenty":-4.744635,"median":-3.575678,"eighty":-2.131737,"marketCap":436508015},{"date":"2023-10-05","current":-1.459971,"twenty":-4.751199,"median":-3.576669,"eighty":-2.134128,"marketCap":383367908},{"date":"2023-10-13","current":-1.474426,"twenty":-4.755016,"median":-3.579398,"eighty":-2.135507,"marketCap":387163630},{"date":"2023-10-20","current":-1.392032,"twenty":-4.756925,"median":-3.581138,"eighty":-2.137245,"marketCap":365528016},{"date":"2023-10-27","current":-1.170868,"twenty":-4.758834,"median":-3.584493,"eighty":-2.147035,"marketCap":307453471},{"date":"2023-11-03","current":-1.228688,"twenty":-4.758834,"median":-3.584493,"eighty":-2.152459,"marketCap":322636358},{"date":"2023-11-10","current":-1.049912,"twenty":-4.758834,"median":-3.584493,"eighty":-2.152459,"marketCap":285969685},{"date":"2023-11-17","current":-0.987001,"twenty":-4.758834,"median":-3.584493,"eighty":-2.152459,"marketCap":267046829},{"date":"2023-11-24","current":-0.97276,"twenty":-4.758834,"median":-3.584493,"eighty":-2.152459,"marketCap":263193725},{"date":"2023-12-01","current":-1.095712,"twenty":-4.758834,"median":-3.584493,"eighty":-2.152459,"marketCap":296460130},{"date":"2023-12-08","current":-1.142806,"twenty":-4.758834,"median":-3.584493,"eighty":-2.143769,"marketCap":309202079},{"date":"2023-12-15","current":-1.073293,"twenty":-4.758834,"median":-3.584493,"eighty":-2.134619,"marketCap":290394352},{"date":"2023-12-22","current":-1.096417,"twenty":-4.758834,"median":-3.584493,"eighty":-2.134619,"marketCap":296650878},{"date":"2023-12-29","current":-1.142101,"twenty":-4.758834,"median":-3.584493,"eighty":-2.135507,"marketCap":309011331},{"date":"2024-01-05","current":-1.095148,"twenty":-4.758834,"median":-3.58557,"eighty":-2.134619,"marketCap":296307532},{"date":"2024-01-12","current":-1.007446,"twenty":-4.758834,"median":-3.58557,"eighty":-2.125169,"marketCap":272578514},{"date":"2024-01-19","current":-0.794394,"twenty":-4.758834,"median":-3.586647,"eighty":-2.107766,"marketCap":214934548},{"date":"2024-01-26","current":-0.845719,"twenty":-4.758834,"median":-3.58557,"eighty":-2.075999,"marketCap":228820983},{"date":"2024-02-02","current":-0.895633,"twenty":-4.758834,"median":-3.58557,"eighty":-2.035084,"marketCap":242325923},{"date":"2024-02-09","current":-0.983194,"twenty":-4.758834,"median":-3.58557,"eighty":-1.99098,"marketCap":266016791},{"date":"2024-02-16","current":-0.964752,"twenty":-4.758834,"median":-3.58557,"eighty":-1.939882,"marketCap":261027212},{"date":"2024-02-23","current":-0.996035,"twenty":-4.758834,"median":-3.58557,"eighty":-1.896517,"marketCap":269491233},{"date":"2024-03-01","current":-0.988965,"twenty":-4.758834,"median":-3.584493,"eighty":-1.85026,"marketCap":267578233},{"date":"2024-03-08","current":-1.035018,"twenty":-4.758834,"median":-3.584493,"eighty":-1.792843,"marketCap":280038593},{"date":"2024-03-15","current":-0.975875,"twenty":-4.758834,"median":-3.584493,"eighty":-1.65367,"marketCap":251226366},{"date":"2024-03-22","current":-0.958317,"twenty":-4.758834,"median":-3.584493,"eighty":-1.538029,"marketCap":235516863},{"date":"2024-03-28","current":-0.94843,"twenty":-4.758834,"median":-3.584493,"eighty":-1.484545,"marketCap":233087127},{"date":"2024-04-05","current":-0.862349,"twenty":-4.758834,"median":-3.58557,"eighty":-1.295732,"marketCap":211931663},{"date":"2024-04-12","current":-0.755983,"twenty":-4.758834,"median":-3.58557,"eighty":-1.171601,"marketCap":185791046},{"date":"2024-04-19","current":-0.423589,"twenty":-4.758834,"median":-3.58557,"eighty":-1.150283,"marketCap":104101634},{"date":"2024-04-26","current":-0.707402,"twenty":-4.758834,"median":-3.584493,"eighty":-1.141509,"marketCap":173851824},{"date":"2024-05-03","current":-1.069542,"twenty":-4.758834,"median":-3.584493,"eighty":-1.12724,"marketCap":262851728},{"date":"2024-05-10","current":-1.028064,"twenty":-4.758834,"median":-3.584493,"eighty":-1.10327,"marketCap":246111338},{"date":"2024-05-17","current":-0.921047,"twenty":-4.758834,"median":-3.575678,"eighty":-1.095374,"marketCap":220492240},{"date":"2024-05-24","current":-1.083327,"twenty":-4.758834,"median":-3.572309,"eighty":-1.076226,"marketCap":259340873},{"date":"2024-05-31","current":-1.325431,"twenty":-4.758834,"median":-3.56471,"eighty":-1.076226,"marketCap":317298833},{"date":"2024-06-07","current":-1.452623,"twenty":-4.758834,"median":-3.552584,"eighty":-1.076226,"marketCap":347747762},{"date":"2024-06-14","current":-1.4035,"twenty":-4.758834,"median":-3.542773,"eighty":-1.074759,"marketCap":335988176},{"date":"2024-06-21","current":-1.190344,"twenty":-4.758834,"median":-3.537907,"eighty":-1.073293,"marketCap":284959971},{"date":"2024-06-28","current":-1.238589,"twenty":-4.762116,"median":-3.528963,"eighty":-1.072785,"marketCap":296509565},{"date":"2024-07-05","current":-1.274554,"twenty":-4.762116,"median":-3.51515,"eighty":-1.072785,"marketCap":305119262},{"date":"2024-07-12","current":-1.349992,"twenty":-4.762116,"median":-3.508598,"eighty":-1.072785,"marketCap":323178626},{"date":"2024-07-15","current":-1.368413,"twenty":-4.762116,"median":-3.503383,"eighty":-1.072785,"marketCap":327588471},{"date":"2024-08-02","current":-0.523681,"twenty":-4.777562,"median":-3.481662,"eighty":-1.070617,"marketCap":125365588},{"date":"2024-08-09","current":-0.509715,"twenty":-4.777562,"median":-3.475136,"eighty":-1.052035,"marketCap":113899848},{"date":"2024-08-16","current":-0.499096,"twenty":-4.777562,"median":-3.475136,"eighty":-1.0353,"marketCap":111526934},{"date":"2024-08-23","current":-0.528057,"twenty":-4.777562,"median":-3.467451,"eighty":-1.011394,"marketCap":117998517},{"date":"2024-08-30","current":-0.481719,"twenty":-4.777562,"median":-3.467451,"eighty":-1.002749,"marketCap":107643985},{"date":"2024-09-06","current":-0.482684,"twenty":-4.777562,"median":-3.465995,"eighty":-0.993799,"marketCap":107859705},{"date":"2024-09-13","current":-0.572464,"twenty":-4.777562,"median":-3.432608,"eighty":-0.988904,"marketCap":127921610},{"date":"2024-09-20","current":-0.578256,"twenty":-4.777562,"median":-3.410608,"eighty":-0.985676,"marketCap":129215926},{"date":"2024-09-27","current":-0.499096,"twenty":-4.777562,"median":-3.383717,"eighty":-0.975109,"marketCap":111526934},{"date":"2024-10-04","current":-0.440208,"twenty":-4.777562,"median":-3.383717,"eighty":-0.972752,"marketCap":98368050},{"date":"2024-10-11","current":-0.410282,"twenty":-4.777562,"median":-3.383717,"eighty":-0.959969,"marketCap":91680749},{"date":"2024-10-18","current":-0.441174,"twenty":-4.777562,"median":-3.383717,"eighty":-0.952469,"marketCap":98583770},{"date":"2024-10-25","current":-0.425728,"twenty":-4.777562,"median":-3.383717,"eighty":-0.940321,"marketCap":95132259},{"date":"2024-10-31","current":-0.423797,"twenty":-4.777562,"median":-3.383717,"eighty":-0.930994,"marketCap":94700820},{"date":"2024-11-08","current":-0.37939,"twenty":-4.777562,"median":-3.374713,"eighty":-0.91572,"marketCap":84777728},{"date":"2024-11-15","current":-0.285452,"twenty":-4.777562,"median":-3.303677,"eighty":-0.897325,"marketCap":64981233},{"date":"2024-11-22","current":-0.294727,"twenty":-4.761022,"median":-3.28271,"eighty":-0.869324,"marketCap":67092536},{"date":"2024-11-29","current":-0.352436,"twenty":-4.761022,"median":-3.252725,"eighty":-0.844647,"marketCap":80229537},{"date":"2024-12-06","current":-0.323581,"twenty":-4.761022,"median":-3.219896,"eighty":-0.822086,"marketCap":73661037},{"date":"2024-12-13","current":-0.317398,"twenty":-4.761022,"median":-3.168467,"eighty":-0.736551,"marketCap":72253501},{"date":"2024-12-20","current":-0.284422,"twenty":-4.761022,"median":-3.145635,"eighty":-0.595633,"marketCap":64746644},{"date":"2024-12-27","current":-0.289574,"twenty":-4.761022,"median":-3.106339,"eighty":-0.570147,"marketCap":65919590},{"date":"2025-01-03","current":-0.318429,"twenty":-4.761022,"median":-3.077193,"eighty":-0.552626,"marketCap":72488090},{"date":"2025-01-10","current":-0.350375,"twenty":-4.762116,"median":-3.05033,"eighty":-0.532191,"marketCap":79760358},{"date":"2025-01-17","current":-0.324612,"twenty":-4.762116,"median":-3.026485,"eighty":-0.512032,"marketCap":73895626},{"date":"2025-01-24","current":-0.387473,"twenty":-4.762116,"median":-2.980497,"eighty":-0.499868,"marketCap":88205573},{"date":"2025-01-31","current":-0.364802,"twenty":-4.762116,"median":-2.925709,"eighty":-0.495234,"marketCap":83044608},{"date":"2025-02-07","current":-0.385412,"twenty":-4.762116,"median":-2.870595,"eighty":-0.491533,"marketCap":87736394},{"date":"2025-02-14","current":-0.36068,"twenty":-4.762116,"median":-2.79954,"eighty":-0.479402,"marketCap":82106251},{"date":"2025-02-21","current":-0.355527,"twenty":-4.758834,"median":-2.764976,"eighty":-0.472606,"marketCap":80933305},{"date":"2025-02-28","current":-0.294727,"twenty":-4.758834,"median":-2.732828,"eighty":-0.45783,"marketCap":67092536},{"date":"2025-03-07","current":-0.242171,"twenty":-4.758834,"median":-2.711023,"eighty":-0.44909,"marketCap":55128483},{"date":"2025-03-14","current":-0.172611,"twenty":-4.758834,"median":-2.681951,"eighty":-0.441367,"marketCap":39293706},{"date":"2025-03-21","current":-0.186019,"twenty":-4.758834,"median":-2.616264,"eighty":-0.433644,"marketCap":42265764},{"date":"2025-03-28","current":-0.184905,"twenty":-4.758834,"median":-2.568557,"eighty":-0.424183,"marketCap":42012676},{"date":"2025-04-04","current":-0.178222,"twenty":-4.758834,"median":-2.531287,"eighty":-0.402997,"marketCap":40494145},{"date":"2025-04-11","current":-0.18045,"twenty":-4.758834,"median":-2.488661,"eighty":-0.391222,"marketCap":41000322},{"date":"2025-04-17","current":-0.183791,"twenty":-4.758834,"median":-2.484485,"eighty":-0.381387,"marketCap":41759587},{"date":"2025-04-25","current":-0.314116,"twenty":-4.758834,"median":-2.475296,"eighty":-0.371191,"marketCap":71370931},{"date":"2025-05-02","current":-0.318572,"twenty":-4.758834,"median":-2.439755,"eighty":-0.365832,"marketCap":72383285},{"date":"2025-05-09","current":-0.363545,"twenty":-4.758834,"median":-2.385601,"eighty":-0.36171,"marketCap":82601840},{"date":"2025-05-16","current":-0.486216,"twenty":-4.758834,"median":-2.379633,"eighty":-0.360886,"marketCap":92668953},{"date":"2025-05-23","current":-0.545195,"twenty":-4.758834,"median":-2.349838,"eighty":-0.360886,"marketCap":103909861},{"date":"2025-05-30","current":-0.460323,"twenty":-4.758834,"median":-2.31951,"eighty":-0.360886,"marketCap":87733920},{"date":"2025-06-06","current":-0.742271,"twenty":-4.758834,"median":-2.289397,"eighty":-0.360886,"marketCap":141470946},{"date":"2025-06-13","current":-0.693362,"twenty":-4.758834,"median":-2.263235,"eighty":-0.360886,"marketCap":132149217},{"date":"2025-06-20","current":-0.643014,"twenty":-4.758834,"median":-2.236155,"eighty":-0.36068,"marketCap":122553319},{"date":"2025-06-27","current":-0.706308,"twenty":-4.758834,"median":-2.20952,"eighty":-0.36068,"marketCap":134616733},{"date":"2025-07-03","current":-0.873176,"twenty":-4.758834,"median":-2.189024,"eighty":-0.36068,"marketCap":166420279},{"date":"2025-07-11","current":-0.851598,"twenty":-4.758834,"median":-2.160595,"eighty":-0.36068,"marketCap":162307752},{"date":"2025-07-18","current":-0.966679,"twenty":-4.758834,"median":-2.122302,"eighty":-0.36068,"marketCap":184241232},{"date":"2025-07-25","current":-0.86886,"twenty":-4.758834,"median":-2.107766,"eighty":-0.36068,"marketCap":165597774},{"date":"2025-08-01","current":-0.794058,"twenty":-4.758834,"median":-2.052632,"eighty":-0.36068,"marketCap":151341012},{"date":"2025-08-08","current":-0.684731,"twenty":-4.758834,"median":-2.01845,"eighty":-0.36068,"marketCap":130504206},{"date":"2025-08-15","current":-0.876202,"twenty":-4.758834,"median":-1.9793,"eighty":-0.36068,"marketCap":144981691},{"date":"2025-08-22","current":-0.880054,"twenty":-4.758834,"median":-1.908081,"eighty":-0.36068,"marketCap":145618973},{"date":"2025-08-29","current":-0.818431,"twenty":-4.758834,"median":-1.85026,"eighty":-0.36068,"marketCap":135422459},{"date":"2025-09-05","current":-0.826134,"twenty":-4.751199,"median":-1.806895,"eighty":-0.36068,"marketCap":136697023},{"date":"2025-09-12","current":-0.912791,"twenty":-4.720153,"median":-1.763529,"eighty":-0.36068,"marketCap":151035871},{"date":"2025-09-19","current":-0.876202,"twenty":-4.639607,"median":-1.590067,"eighty":-0.36068,"marketCap":144981691},{"date":"2025-09-26","current":-0.751031,"twenty":-4.603027,"median":-1.532247,"eighty":-0.36068,"marketCap":124270021},{"date":"2025-10-03","current":-0.758733,"twenty":-4.603027,"median":-1.488588,"eighty":-0.36068,"marketCap":125544585},{"date":"2025-10-10","current":-0.818431,"twenty":-4.584765,"median":-1.469289,"eighty":-0.36068,"marketCap":135422459},{"date":"2025-10-17","current":-0.768362,"twenty":-4.529097,"median":-1.4035,"eighty":-0.36068,"marketCap":127137790},{"date":"2025-10-24","current":-0.804951,"twenty":-4.504844,"median":-1.364904,"eighty":-0.36068,"marketCap":133191971},{"date":"2025-10-31","current":-0.733699,"twenty":-4.504844,"median":-1.327185,"eighty":-0.36068,"marketCap":121402251},{"date":"2025-11-07","current":-0.739476,"twenty":-4.504844,"median":-1.274554,"eighty":-0.36068,"marketCap":122358174},{"date":"2025-11-14","current":-3.923437,"twenty":-4.502695,"median":-1.274554,"eighty":-0.36068,"marketCap":137971587},{"date":"2025-11-21","current":-4.148775,"twenty":-4.502695,"median":-1.274554,"eighty":-0.36068,"marketCap":145895817},{"date":"2025-11-28","current":-4.409887,"twenty":-4.502695,"median":-1.274554,"eighty":-0.36068,"marketCap":155078071},{"date":"2025-12-05","current":-3.926346,"twenty":-4.502695,"median":-1.274554,"eighty":-0.36068,"marketCap":138073896},{"date":"2025-12-12","current":-3.945688,"twenty":-4.502695,"median":-1.274554,"eighty":-0.36068,"marketCap":138754063},{"date":"2025-12-19","current":-3.394452,"twenty":-4.502695,"median":-1.274554,"eighty":-0.36068,"marketCap":119369304},{"date":"2025-12-26","current":-3.239719,"twenty":-4.502695,"median":-1.274554,"eighty":-0.36068,"marketCap":113927969},{"date":"2026-01-02","current":-3.036632,"twenty":-4.502695,"median":-1.274554,"eighty":-0.36068,"marketCap":106786215},{"date":"2026-01-09","current":-3.626551,"twenty":-4.502695,"median":-1.274554,"eighty":-0.36068,"marketCap":127531308},{"date":"2026-01-16","current":-3.558856,"twenty":-4.504844,"median":-1.274554,"eighty":-0.36068,"marketCap":125150724},{"date":"2026-01-23","current":-3.268732,"twenty":-4.504844,"median":-1.274554,"eighty":-0.36068,"marketCap":114948219},{"date":"2026-01-30","current":-2.89157,"twenty":-4.504844,"median":-1.274554,"eighty":-0.36068,"marketCap":101684963},{"date":"2026-02-06","current":-2.678813,"twenty":-4.430404,"median":-1.274554,"eighty":-0.36068,"marketCap":94203126},{"date":"2026-02-13","current":-2.756179,"twenty":-4.343462,"median":-1.274554,"eighty":-0.36068,"marketCap":96923794},{"date":"2026-02-19","current":-2.978608,"twenty":-4.296149,"median":-1.274554,"eighty":-0.36068,"marketCap":104745714}],"updateTime":1771653881754},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AGEN\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2612374280","title":"Agenus Inc. Publishes Findings on Systemic and Tumor-Microenvironment Inflammation in Botensilimab-Treated Cold, Refractory Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2612374280","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612374280?lang=en_us&edition=fundamental","pubTime":"2026-02-20 04:17","pubTimestamp":1771532254,"startTime":"0","endTime":"0","summary":"Agenus Inc. Publishes Findings on Systemic and Tumor-Microenvironment Inflammation in Botensilimab-Treated Cold, Refractory Tumors. Agenus Inc. published a medical research presentation on how systemic inflammation and tumor-microenvironment immune features are associated with outcomes in patients with immunologically cold, treatment-refractory tumors treated with botensilimab, including in combination with balstilimab. The document summarizes efficacy and overall survival analyses, compares outcomes by prior immune checkpoint inhibitor exposure and early immune-mediated adverse events, and reports exploratory biomarker findings from the C-800-01 clinical trial. The full document can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260219:nNDL4KF7pg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGEN","BK4139"],"gpt_icon":0},{"id":"2612280376","title":"Agenus reports biomarker data showing survival stratification in MSS mCRC patients treated with botensilimab plus balstilimab","url":"https://stock-news.laohu8.com/highlight/detail?id=2612280376","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612280376?lang=en_us&edition=fundamental","pubTime":"2026-02-20 04:15","pubTimestamp":1771532115,"startTime":"0","endTime":"0","summary":"Agenus reports biomarker data showing survival stratification in MSS mCRC patients treated with botensilimab plus balstilimab. Agenus Inc. announced new translational and clinical biomarker findings from its Phase 1b C-800-01 trial  evaluating botensilimab  in combination with balstilimab  in advanced, treatment-refractory cancers, including microsatellite-stable metastatic colorectal cancer . The company reported outcomes in 341 efficacy-evaluable patients with available biomarker data , including an objective response rate of 17%, a clinical benefit rate of 26%, and a median overall survival of 17.2 months, and described analyses integrating blood-based inflammation markers with tumor immune features to stratify survival in MSS mCRC. The data were presented at the AACR Immuno-Oncology Conference in Los Angeles.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260219:nNDL4jNvD1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AGEN"],"gpt_icon":0},{"id":"2610650919","title":"Agenus stellt neue klinische Daten zu Botensilimab bei therapieresistenten Tumoren vor","url":"https://stock-news.laohu8.com/highlight/detail?id=2610650919","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610650919?lang=en_us&edition=fundamental","pubTime":"2026-02-10 02:00","pubTimestamp":1770660024,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Agenus Inc. published the original content used to generate this news brief via Business Wire  on February 09, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nNDLc92SBb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGEN","BK4139"],"gpt_icon":0},{"id":"2605048610","title":"Analysts Offer Insights on Healthcare Companies: Argenx Se (ARGX), Agenus (AGEN) and Assertio Therapeutics (ASRT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2605048610","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605048610?lang=en_us&edition=fundamental","pubTime":"2026-01-21 23:30","pubTimestamp":1769009415,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Argenx Se (ARGX – Research Report), Agenus (AGEN – R...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-argenx-se-argx-agenus-agen-and-assertio-therapeutics-asrt-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-argenx-se-argx-agenus-agen-and-assertio-therapeutics-asrt-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B2B36J28.USD","ASRT","BK4505","BK4539","HCSG","BK4007","BK4139","LU1983260115.SGD","LU0128526141.USD","IE0002141913.USD","IE0009355771.USD","LU0889565916.HKD","BK4137","LU0029874061.USD","BK4588","LU0320765992.SGD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","LABU","LENZ","IE00B4R5TH58.HKD","BK4585","XLV","LU0109394709.USD","XBI","LU2324357040.USD","AGEN","ARGX","BK4581","IE0034235188.USD"],"gpt_icon":0},{"id":"2605678104","title":"Agenus Expands Medical Affairs Infrastructure Amid Rising Demand for Botensilimab Access","url":"https://stock-news.laohu8.com/highlight/detail?id=2605678104","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605678104?lang=en_us&edition=fundamental","pubTime":"2026-01-21 20:30","pubTimestamp":1768998615,"startTime":"0","endTime":"0","summary":"Agenus Inc. has expanded its global Medical Affairs infrastructure to support growing physician interest in authorized access to its investigational immunotherapy combination, botensilimab plus balstilimab . The expansion aims to facilitate scientific exchange, coordinate access requests, support pharmacovigilance, and enable structured collection of real-world safety and outcomes data. This scale-up also supports France's multi-tumor AAC access framework and the company's expanding paid named-patient programs in select countries.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Agenus Inc. published the original content used to generate this news brief via Business Wire  on January 21, 2026, and is solely responsible for the information","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nNDL3W2Nr5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AGEN"],"gpt_icon":0},{"id":"2605147753","title":"Agenus Launches Stakeholder Webcast Showcasing Global Momentum for BOT+BAL Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2605147753","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605147753?lang=en_us&edition=fundamental","pubTime":"2026-01-21 07:24","pubTimestamp":1768951452,"startTime":"0","endTime":"0","summary":"Agenus Inc. will host its first Stakeholder Webcast of 2026, titled \"Access to Acceleration: Agenus' Global Momentum Entering 2026,\" on Wednesday, January 28, 2026, at 4:00 p.m. ET. The event will focus on expanding global access pathways, strategic partnerships, and operational readiness for the company's botensilimab and balstilimab  program. The session will include insights from Agenus leadership and international oncology experts, with discussion on clinical development, authorized access programs, and priorities for the coming year.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Agenus Inc. published the original content used to generate this news brief via Business Wire  on January 20, 2026, and is solely responsible for the inf","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nNDL7XJXst:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AGEN"],"gpt_icon":0},{"id":"2604196439","title":"Agenus Inc. Files Initial Beneficial Ownership Statement for Principal Accounting Officer Austin Charette","url":"https://stock-news.laohu8.com/highlight/detail?id=2604196439","media":"Reuters","labels":["executive","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604196439?lang=en_us&edition=fundamental","pubTime":"2026-01-17 05:06","pubTimestamp":1768597566,"startTime":"0","endTime":"0","summary":"Agenus Inc. has filed an initial statement of beneficial ownership with the SEC. The filing names Austin Charette, who serves as Principal Accounting Officer, as the beneficial owner. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Agenus Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 16, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260116:nNDL11MlPW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Agenus Inc. Files Initial Beneficial Ownership Statement for Principal Accounting Officer Austin Charette","news_tag":"executive,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AGEN"],"gpt_icon":0},{"id":"2603991845","title":"Agenus Forms Major Strategic Collaboration with Zydus Lifesciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2603991845","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603991845?lang=en_us&edition=fundamental","pubTime":"2026-01-16 21:58","pubTimestamp":1768571889,"startTime":"0","endTime":"0","summary":"An announcement from Agenus ( ($AGEN) ) is now available. On January 15, 2026, Agenus closed a $141 million strategic collaboration with Zydus Life...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/agenus-forms-major-strategic-collaboration-with-zydus-lifesciences?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/agenus-forms-major-strategic-collaboration-with-zydus-lifesciences?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AGEN","BK4139"],"gpt_icon":0},{"id":"2603980629","title":"Agenus Falls After $141M Zydus Deal Closes","url":"https://stock-news.laohu8.com/highlight/detail?id=2603980629","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603980629?lang=en_us&edition=fundamental","pubTime":"2026-01-16 02:29","pubTimestamp":1768501740,"startTime":"0","endTime":"0","summary":"Shares of Agenus slipped after the oncology company closed a $141 million deal with Zydus Lifesciences.Agenus stock slid 20%, to $3.73, midday Thursday. Shares are down 6.9% over the past three months.Through the deal, which was first announced in June 2025, the Lexington, Mass., company sold two of its biologics manufacturing facilities in California to Zydus for $75 million in cash.The Indian company also made a $16 million equity investment in Agenus, which amounts to 2.1 million shares at $7.50 apiece.Zydus also plans to make payments of up to $50 million contingent on milestones of BOT and BAL production orders.Agenus is giving Zydus exclusive rights to develop and commercialize BOT and BAL in India and Sri Lanka. Agenus would be eligible to receive a 5% royalty on net sales in those countries.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AGEN"],"gpt_icon":0},{"id":"2603988100","title":"Zydus Lifesciences Closes Acquisition of Agenus Biologics Facilities and Launches Zylidac Bio in US","url":"https://stock-news.laohu8.com/highlight/detail?id=2603988100","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603988100?lang=en_us&edition=fundamental","pubTime":"2026-01-15 21:31","pubTimestamp":1768483898,"startTime":"0","endTime":"0","summary":"Zydus Lifesciences Limited has completed the acquisition of Agenus Inc.'s biologics manufacturing facilities in the United States and launched Zylidac Bio LLC to expand its presence in the U.S. market. Under the terms of the finalized agreements, Zydus will be the sole manufacturer for Agenus’ Phase 3 immuno-oncology candidates, botensilimab and balstilimab, and has secured exclusive rights to commercialize these assets in India and Sri Lanka. The transaction also includes a strategic collaboration, leveraging Agenus’ immunotherapy pipeline and Zydus’ global manufacturing and commercial infrastructure. This update follows the receipt of all necessary regulatory approvals.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Agenus Inc. publi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260115:nNDL6yc8sS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AGEN"],"gpt_icon":0},{"id":"2603776604","title":"Agenus Closes $141M Strategic Collaboration with Zydus Lifesciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2603776604","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603776604?lang=en_us&edition=fundamental","pubTime":"2026-01-15 20:01","pubTimestamp":1768478481,"startTime":"0","endTime":"0","summary":"Agenus Inc. has announced the closing of a $141 million strategic collaboration with Zydus Lifesciences Ltd. The agreement aims to accelerate the global development and potential commercialization of Agenus’ botensilimab and balstilimab  immunotherapy combination program. As part of the deal, Zydus will pay Agenus $75 million in cash for the transfer of biologics manufacturing facilities in California and will make a $16 million equity investment. Additionally, Agenus is eligible for up to $50 million in milestone payments and will receive a 5% royalty on net sales of BOT and BAL in India and Sri Lanka, where Zydus will hold exclusive development and commercialization rights. The partnership also secures long-term U.S. manufacturing capacity to support Agenus’ clinical and commercial activities.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260115:nNDLL0hLy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AGEN"],"gpt_icon":0},{"id":"2603642230","title":"Agenus Consolidates Financial Leadership With Interim CFO Appointment","url":"https://stock-news.laohu8.com/highlight/detail?id=2603642230","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603642230?lang=en_us&edition=fundamental","pubTime":"2026-01-15 05:33","pubTimestamp":1768426428,"startTime":"0","endTime":"0","summary":"Agenus ( ($AGEN) ) has shared an announcement. Effective January 8, 2026, Agenus Inc.’s board appointed Chairman and Chief Executive Officer Dr. Ga...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/agenus-consolidates-financial-leadership-with-interim-cfo-appointment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/agenus-consolidates-financial-leadership-with-interim-cfo-appointment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","AGEN"],"gpt_icon":0},{"id":"2603644068","title":"Agenus Inc - Effective Jan 8, Appointed CEO Garo Armen as Interim CFO - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2603644068","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603644068?lang=en_us&edition=fundamental","pubTime":"2026-01-15 05:11","pubTimestamp":1768425066,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260114:nFWN3YF21C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","AGEN"],"gpt_icon":0},{"id":"2603447446","title":"Agenus Names CEO Garo Armen as Interim CFO, Appoints Austin Charette as Principal Accounting Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2603447446","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603447446?lang=en_us&edition=fundamental","pubTime":"2026-01-15 05:09","pubTimestamp":1768424985,"startTime":"0","endTime":"0","summary":"Agenus Inc. announced that Dr. Garo Armen, the company’s Chairman and CEO, has been appointed interim Chief Financial Officer and Principal Financial Officer, effective January 8, 2026. In addition, Austin Charette, currently Senior Director of Financial Reporting and Compliance, has been named Principal Accounting Officer.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Agenus Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 14, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260114:nNDLbB949c:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AGEN"],"gpt_icon":0},{"id":"2602651272","title":"Agenus Inc - France's Ansm Approves Updated Protocol for Botensilimab + Balstilimab","url":"https://stock-news.laohu8.com/highlight/detail?id=2602651272","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602651272?lang=en_us&edition=fundamental","pubTime":"2026-01-12 20:35","pubTimestamp":1768221309,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nFWN3YD0SM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","AGEN"],"gpt_icon":0},{"id":"2602512705","title":"Agenus Inc - BOT+Bal Remains Investigational, Not Approved for Marketing in France or Elsewhere","url":"https://stock-news.laohu8.com/highlight/detail?id=2602512705","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602512705?lang=en_us&edition=fundamental","pubTime":"2026-01-12 20:35","pubTimestamp":1768221309,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nFWN3YD0SM:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AGEN","BK4139"],"gpt_icon":0},{"id":"2602512235","title":"France Expands Compassionate Access for Agenus Botensilimab and Balstilimab Combination","url":"https://stock-news.laohu8.com/highlight/detail?id=2602512235","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602512235?lang=en_us&edition=fundamental","pubTime":"2026-01-12 20:30","pubTimestamp":1768221035,"startTime":"0","endTime":"0","summary":"Agenus Inc. announced that France's National Agency for Medicines and Health Products Safety  has approved an updated national treatment protocol for the investigational immunotherapy combination of botensilimab and balstilimab under the Autorisation d'Accès Compassionnel  framework. The revised protocol expands fully reimbursed, hospital-based compassionate access to include eligible patients with advanced or metastatic ovarian cancer and soft-tissue sarcomas, in addition to previously authorized access for patients with microsatellite-stable metastatic colorectal cancer without active liver metastases. This update broadens patient eligibility and standardizes treatment and monitoring procedures across participating French hospitals. Botensilimab and balstilimab remain investigational and are not approved for commercial marketing.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely i","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nNDL86Jj9h:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGEN","BK4139"],"gpt_icon":0},{"id":"2602313168","title":"Agenus amends Ligand agreement, modifies warrant holder rights","url":"https://stock-news.laohu8.com/highlight/detail?id=2602313168","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602313168?lang=en_us&edition=fundamental","pubTime":"2026-01-09 05:29","pubTimestamp":1767907773,"startTime":"0","endTime":"0","summary":"Agenus ( ($AGEN) ) just unveiled an update. On January 3, 2026, Agenus Inc., together with Agenus Royalty Fund, LLC and Agenus Holdings 2024, LLC, ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/agenus-amends-ligand-agreement-modifies-warrant-holder-rights?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/agenus-amends-ligand-agreement-modifies-warrant-holder-rights?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AGEN","BK4139"],"gpt_icon":0},{"id":"2593490731","title":"Agenus Reports Promising Results for Botensilimab and Balstilimab in Refractory Ovarian Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2593490731","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593490731?lang=en_us&edition=fundamental","pubTime":"2025-12-23 21:05","pubTimestamp":1766495120,"startTime":"0","endTime":"0","summary":"Agenus Inc. has announced the publication of clinical results from the ovarian cancer cohort of its Phase 1b C-800-01 trial evaluating botensilimab plus balstilimab  in The Journal for ImmunoTherapy of Cancer . The study included women with treatment-refractory ovarian cancer, a population with limited remaining treatment options. In this heavily pretreated group, BOT+BAL demonstrated a 23% overall response rate and a 31% clinical benefit rate, with a median duration of response of 9.7 months. Median overall survival reached 14.8 months, with an estimated 75% of patients alive at 12 months. These results have already been published and build on data from the broader C-800-01 dataset previously presented at ESMO 2025. Agenus is continuing global clinical development of BOT+BAL across multiple tumor types and is providing access to the combination through early access programs in select countries.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nNDL7LNgD9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AGEN"],"gpt_icon":0},{"id":"2592195537","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 10:33 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2592195537","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592195537?lang=en_us&edition=fundamental","pubTime":"2025-12-19 23:33","pubTimestamp":1766158405,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 10:33 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nAQN2LEFF9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AGEN"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":46,"code":"91000000","status":"200"}]}}